{"id":52603,"date":"2023-01-05T20:02:15","date_gmt":"2023-01-05T19:02:15","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/alveo-technologies-and-government-of-barbados-collaborate-to-co-develop-advanced-molecular-disease-diagnostics-across-multiple-end-markets\/"},"modified":"2023-01-05T20:02:15","modified_gmt":"2023-01-05T19:02:15","slug":"alveo-technologies-and-government-of-barbados-collaborate-to-co-develop-advanced-molecular-disease-diagnostics-across-multiple-end-markets","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/alveo-technologies-and-government-of-barbados-collaborate-to-co-develop-advanced-molecular-disease-diagnostics-across-multiple-end-markets\/","title":{"rendered":"Alveo Technologies and Government of Barbados Collaborate to Co-Develop Advanced Molecular Disease Diagnostics Across Multiple End Markets"},"content":{"rendered":"<div>\n<p class=\"bwalignc\">\n<i>Collaboration supports emergence of Barbados as a life sciences hub in the Caribbean; Accelerates Alveo\u2019s be.well\u2122 platform adoption in new and adjacent markets<\/i>\n<\/p>\n<p>ALAMEDA, Calif.&#8211;(BUSINESS WIRE)&#8211;<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.alveotechnologies.com%2F&amp;esheet=53173390&amp;newsitemid=20230105005924&amp;lan=en-US&amp;anchor=Alveo+Technologies%2C+Inc.&amp;index=1&amp;md5=8b2be327f110b716b87b74176bf27178\" rel=\"nofollow noopener\" shape=\"rect\">Alveo Technologies, Inc.<\/a>, (Alveo) a leader in molecular sensing and diagnostics with its proprietary be.well\u2122 technology platform, in its quest to drive earlier detection of pathogens at the point of need, today announced it has signed a Memorandum of Understanding (MOU) with the Barbados Investment and Development Corporation (Export Barbados (BIDC)) to co-develop on its novel molecular sensing platform, while contributing to the growth of the life sciences industry in the Caribbean nation. This partnership further demonstrates Alveo\u2019s open-source platform development strategy with the aim squarely on making its platform universally accessible across many testing modalities.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20230105005924\/en\/1638519\/5\/Alveo_Technologies%2C_Inc.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20230105005924\/en\/1638519\/21\/Alveo_Technologies%2C_Inc.jpg\"><\/a><\/p>\n<p>\nAlveo has developed a rapid, handheld, portable, and eco-friendly platform that pairs advanced molecular assays with cloud-enabled data analytics for real-time disease, pathogen and contaminant detection, analysis, and diagnosis at point of need.\n<\/p>\n<p>\nExport Barbados (BIDC) is the agency of the Government of Barbados with specific responsibility for promoting and facilitating industrial and export development and sits under the umbrella of the Ministry of Industry, Innovation, Science and Technology. As part of its mandate Export Barbados (BIDC) also has responsibility for advancing the life sciences industry of Barbados.\n<\/p>\n<p>\nThe MOU between Alveo and Export Barbados (BIDC) outlines three initial areas of collaboration:\n<\/p>\n<ul class=\"bwlistdisc\">\n<li>\nCo-development partners: Alveo\u2019s be.well\u2122 platform is a point of need molecular diagnostic and sensing platform that utilizes the company\u2019s proprietary and globally patented method for the direct electrical sensing of nucleic acid amplification. Using this highly sensitive and multiplexed molecular testing platform, Barbados\u2019 top scientists and life sciences industry leaders will design new assays in the areas of infectious disease, agriculture, veterinary, food, medicine, and aquaculture testing.\n<\/li>\n<li>\nBring the be.well\u2122 COVID-19 test to Barbados: BIDC will spearhead the procurement of be.well\u2122 COVID-19 tests and analyzers for use in doctor\u2019s offices, laboratories, and other point-of-care settings. The future goal is to have the tests available for use by individuals in every Barbadian home.\n<\/li>\n<li>\nRefine Alveo\u2019s next-generation be.well\u2122 platforms: Barbados\u2019 life sciences leaders will beta test Alveo\u2019s new high-throughput desktop be.well\u2122 platform, which combines 10 reusable portable analyzers for simultaneous use, designed for higher volume testing in labs and clinics.\n<\/li>\n<\/ul>\n<p>\n\u201cWe are thrilled to have come to this mutual agreement with the government of Barbados, and true to our open-source philosophy toward innovation, we look forward to making progress together,\u201d says Alveo CEO Shaun Holt. \u201cBarbados has an emerging life sciences ecosystem with tremendous potential. This collaboration makes highly sensitive molecular testing broadly accessible in Barbados, potentially improving healthcare for individuals, while providing a platform for innovation for the life sciences community. Our open-source partnering model will tap into Barbados\u2019s deep life science capabilities and rapidly develop additional be.well\u2122 solutions; customers win from the expanded testing library, and Barbados wins from shared revenue and IP ownership.\u201d\n<\/p>\n<p>\n\u201cMany efforts have been underway in recent years to develop Barbados into a biotechnology hub in the Caribbean,\u201d says Mark Hill, CEO of Export Barbados (BIDC). \u201cWe are pleased to partner with Alveo Technologies and explore new applications for this exciting molecular diagnostic technology in the life sciences.\u201d\n<\/p>\n<p>\n<b>About Alveo<br \/>\n<br \/><\/b>At Alveo we understand the importance of access to cutting-edge molecular testing and cloud-based data analytics for rapid diagnosis and management of infectious diseases and other pathogens. With an initial focus on acute respiratory infections including COVID-19, Flu A\/B and RSV, Alveo\u2019s agile and dynamic molecular diagnostic platform, be.well\u2122, can be adapted to detect a wide range of diseases, bacteria, and other pathogens that threaten public health, across all modalities. We believe increased access to real-time test results will transform the way individuals, healthcare providers and public health professionals identify and manage pathogens in humans, animals, plants, water, and beyond. With be.well\u2122, we will Know Sooner, Act Faster\u2122.\n<\/p>\n<p>\nTo learn more, visit <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Falveotechnologies.com&amp;esheet=53173390&amp;newsitemid=20230105005924&amp;lan=en-US&amp;anchor=https%3A%2F%2Falveotechnologies.com&amp;index=2&amp;md5=02e254d9c530c6ee3205146e53521650\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/alveotechnologies.com<\/a><br \/><a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fexportbarbados.org%2F&amp;esheet=53173390&amp;newsitemid=20230105005924&amp;lan=en-US&amp;anchor=https%3A%2F%2Fexportbarbados.org&amp;index=3&amp;md5=68ed6d77f13f66534bf4700752194ed2\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/exportbarbados.org<\/a>\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\n<b>Media:<\/b><br \/>Staci Vernick for Alveo Technologies, Inc.<br \/>\n<br \/>SL Vernick Communications<br \/>\n<br \/>610-812-6092\/<a target=\"_blank\" href=\"m&#97;&#x69;&#x6c;t&#111;&#x3a;&#x73;v&#101;&#114;&#x6e;&#x69;c&#107;&#x40;&#x63;o&#109;&#x63;&#x61;s&#116;&#46;&#x6e;&#x65;t\" rel=\"nofollow noopener\" shape=\"rect\">&#x73;&#118;&#x65;&#114;n&#x69;&#99;k&#x40;&#99;&#x6f;&#x6d;c&#x61;&#115;t&#x2e;&#110;&#x65;&#x74;<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Collaboration supports emergence of Barbados as a life sciences hub in the Caribbean; Accelerates Alveo\u2019s be.well\u2122 platform adoption in new and adjacent markets ALAMEDA, Calif.&#8211;(BUSINESS WIRE)&#8211;Alveo Technologies, Inc., (Alveo) a leader in molecular sensing and diagnostics with its proprietary be.well\u2122 technology platform, in its quest to drive earlier detection of pathogens at the point of &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/alveo-technologies-and-government-of-barbados-collaborate-to-co-develop-advanced-molecular-disease-diagnostics-across-multiple-end-markets\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-52603","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Alveo Technologies and Government of Barbados Collaborate to Co-Develop Advanced Molecular Disease Diagnostics Across Multiple End Markets - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/alveo-technologies-and-government-of-barbados-collaborate-to-co-develop-advanced-molecular-disease-diagnostics-across-multiple-end-markets\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Alveo Technologies and Government of Barbados Collaborate to Co-Develop Advanced Molecular Disease Diagnostics Across Multiple End Markets - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Collaboration supports emergence of Barbados as a life sciences hub in the Caribbean; Accelerates Alveo\u2019s be.well\u2122 platform adoption in new and adjacent markets ALAMEDA, Calif.&#8211;(BUSINESS WIRE)&#8211;Alveo Technologies, Inc., (Alveo) a leader in molecular sensing and diagnostics with its proprietary be.well\u2122 technology platform, in its quest to drive earlier detection of pathogens at the point of ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/alveo-technologies-and-government-of-barbados-collaborate-to-co-develop-advanced-molecular-disease-diagnostics-across-multiple-end-markets\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-01-05T19:02:15+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230105005924\/en\/1638519\/21\/Alveo_Technologies%2C_Inc.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/alveo-technologies-and-government-of-barbados-collaborate-to-co-develop-advanced-molecular-disease-diagnostics-across-multiple-end-markets\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/alveo-technologies-and-government-of-barbados-collaborate-to-co-develop-advanced-molecular-disease-diagnostics-across-multiple-end-markets\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Alveo Technologies and Government of Barbados Collaborate to Co-Develop Advanced Molecular Disease Diagnostics Across Multiple End Markets\",\"datePublished\":\"2023-01-05T19:02:15+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/alveo-technologies-and-government-of-barbados-collaborate-to-co-develop-advanced-molecular-disease-diagnostics-across-multiple-end-markets\\\/\"},\"wordCount\":700,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/alveo-technologies-and-government-of-barbados-collaborate-to-co-develop-advanced-molecular-disease-diagnostics-across-multiple-end-markets\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230105005924\\\/en\\\/1638519\\\/21\\\/Alveo_Technologies%2C_Inc.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/alveo-technologies-and-government-of-barbados-collaborate-to-co-develop-advanced-molecular-disease-diagnostics-across-multiple-end-markets\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/alveo-technologies-and-government-of-barbados-collaborate-to-co-develop-advanced-molecular-disease-diagnostics-across-multiple-end-markets\\\/\",\"name\":\"Alveo Technologies and Government of Barbados Collaborate to Co-Develop Advanced Molecular Disease Diagnostics Across Multiple End Markets - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/alveo-technologies-and-government-of-barbados-collaborate-to-co-develop-advanced-molecular-disease-diagnostics-across-multiple-end-markets\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/alveo-technologies-and-government-of-barbados-collaborate-to-co-develop-advanced-molecular-disease-diagnostics-across-multiple-end-markets\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230105005924\\\/en\\\/1638519\\\/21\\\/Alveo_Technologies%2C_Inc.jpg\",\"datePublished\":\"2023-01-05T19:02:15+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/alveo-technologies-and-government-of-barbados-collaborate-to-co-develop-advanced-molecular-disease-diagnostics-across-multiple-end-markets\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/alveo-technologies-and-government-of-barbados-collaborate-to-co-develop-advanced-molecular-disease-diagnostics-across-multiple-end-markets\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/alveo-technologies-and-government-of-barbados-collaborate-to-co-develop-advanced-molecular-disease-diagnostics-across-multiple-end-markets\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230105005924\\\/en\\\/1638519\\\/21\\\/Alveo_Technologies%2C_Inc.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230105005924\\\/en\\\/1638519\\\/21\\\/Alveo_Technologies%2C_Inc.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/alveo-technologies-and-government-of-barbados-collaborate-to-co-develop-advanced-molecular-disease-diagnostics-across-multiple-end-markets\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Alveo Technologies and Government of Barbados Collaborate to Co-Develop Advanced Molecular Disease Diagnostics Across Multiple End Markets\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Alveo Technologies and Government of Barbados Collaborate to Co-Develop Advanced Molecular Disease Diagnostics Across Multiple End Markets - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/alveo-technologies-and-government-of-barbados-collaborate-to-co-develop-advanced-molecular-disease-diagnostics-across-multiple-end-markets\/","og_locale":"en_US","og_type":"article","og_title":"Alveo Technologies and Government of Barbados Collaborate to Co-Develop Advanced Molecular Disease Diagnostics Across Multiple End Markets - Pharma Trend","og_description":"Collaboration supports emergence of Barbados as a life sciences hub in the Caribbean; Accelerates Alveo\u2019s be.well\u2122 platform adoption in new and adjacent markets ALAMEDA, Calif.&#8211;(BUSINESS WIRE)&#8211;Alveo Technologies, Inc., (Alveo) a leader in molecular sensing and diagnostics with its proprietary be.well\u2122 technology platform, in its quest to drive earlier detection of pathogens at the point of ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/alveo-technologies-and-government-of-barbados-collaborate-to-co-develop-advanced-molecular-disease-diagnostics-across-multiple-end-markets\/","og_site_name":"Pharma Trend","article_published_time":"2023-01-05T19:02:15+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230105005924\/en\/1638519\/21\/Alveo_Technologies%2C_Inc.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/alveo-technologies-and-government-of-barbados-collaborate-to-co-develop-advanced-molecular-disease-diagnostics-across-multiple-end-markets\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/alveo-technologies-and-government-of-barbados-collaborate-to-co-develop-advanced-molecular-disease-diagnostics-across-multiple-end-markets\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Alveo Technologies and Government of Barbados Collaborate to Co-Develop Advanced Molecular Disease Diagnostics Across Multiple End Markets","datePublished":"2023-01-05T19:02:15+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/alveo-technologies-and-government-of-barbados-collaborate-to-co-develop-advanced-molecular-disease-diagnostics-across-multiple-end-markets\/"},"wordCount":700,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/alveo-technologies-and-government-of-barbados-collaborate-to-co-develop-advanced-molecular-disease-diagnostics-across-multiple-end-markets\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230105005924\/en\/1638519\/21\/Alveo_Technologies%2C_Inc.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/alveo-technologies-and-government-of-barbados-collaborate-to-co-develop-advanced-molecular-disease-diagnostics-across-multiple-end-markets\/","url":"https:\/\/pharma-trend.com\/en\/alveo-technologies-and-government-of-barbados-collaborate-to-co-develop-advanced-molecular-disease-diagnostics-across-multiple-end-markets\/","name":"Alveo Technologies and Government of Barbados Collaborate to Co-Develop Advanced Molecular Disease Diagnostics Across Multiple End Markets - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/alveo-technologies-and-government-of-barbados-collaborate-to-co-develop-advanced-molecular-disease-diagnostics-across-multiple-end-markets\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/alveo-technologies-and-government-of-barbados-collaborate-to-co-develop-advanced-molecular-disease-diagnostics-across-multiple-end-markets\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230105005924\/en\/1638519\/21\/Alveo_Technologies%2C_Inc.jpg","datePublished":"2023-01-05T19:02:15+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/alveo-technologies-and-government-of-barbados-collaborate-to-co-develop-advanced-molecular-disease-diagnostics-across-multiple-end-markets\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/alveo-technologies-and-government-of-barbados-collaborate-to-co-develop-advanced-molecular-disease-diagnostics-across-multiple-end-markets\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/alveo-technologies-and-government-of-barbados-collaborate-to-co-develop-advanced-molecular-disease-diagnostics-across-multiple-end-markets\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230105005924\/en\/1638519\/21\/Alveo_Technologies%2C_Inc.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230105005924\/en\/1638519\/21\/Alveo_Technologies%2C_Inc.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/alveo-technologies-and-government-of-barbados-collaborate-to-co-develop-advanced-molecular-disease-diagnostics-across-multiple-end-markets\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Alveo Technologies and Government of Barbados Collaborate to Co-Develop Advanced Molecular Disease Diagnostics Across Multiple End Markets"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/52603","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=52603"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/52603\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=52603"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=52603"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=52603"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}